Louise Burke, Lindy Castell, Joanna Harper and Angela Cheruiyot
Today – February 11 – marks the sixth annual International Day of Women and Girls in Science, established by the United Nations General Assembly “in order to achieve full and equal access to and participation in science for women and girls”.
According to data for 2014 to 2016 produced by the United Nations Educational, Scientific and Cultural Organisation (UNESCO), only about 30% of all female students select fields related to science, technology, engineering and mathematics in higher education.
“Long-standing biases and gender stereotypes are steering girls and women away from science related fields,” the UN site adds.
University of Warwick: COVID-19 vaccine impact forecast, 13 January 2021 Request an accessible format. If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email contact@go-science.gov.uk.
Please tell us what format you need. It will help us if you say what assistive technology you use.
Details
NPIs) scenarios. This paper was presented at
The paper is the assessment of the evidence at the time of writing. As new evidence or data emerges,
SAGE updates its advice accordingly.
NPIs.
These documents are released as pre-print publications that have provided the government with rapid evidence during an emergency. These documents have not been peer-reviewed and there is no restriction on authors submitting and publishing this evidence in peer-reviewed journals.
Imperial College London: Potential profile of the COVID-19 epidemic in the UK under different vaccination roll out strategies, 13 January 2021 Request an accessible format. If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email contact@go-science.gov.uk.
Please tell us what format you need. It will help us if you say what assistive technology you use.
Details
NPIs) scenarios. It was considered at
The paper is the assessment of the evidence at the time of writing. As new evidence or data emerges,
SAGE updates its advice accordingly.
FDA approves GSK s BENLYSTA as the first medicine for adult patients with active lupus nephritis in the US
Approval builds on nearly 10 years of experience in lupus
News provided by
Share this article
Share this article
LONDON, Dec. 17, 2020 /PRNewswire/ GlaxoSmithKline plc (LSE/NYSE: GSK) announced the US Food and Drug Administration (FDA) has approved BENLYSTA (belimumab) for the treatment of adult patients with active lupus nephritis (LN) who are receiving standard therapy. Lupus nephritis is a serious inflammation of the kidneys caused by systemic lupus erythematosus (SLE), the most common form of lupus, which can lead to end-stage kidney disease, requiring dialysis or a kidney transplant. The approval extends the current indication in the US to include both SLE and LN for both the intravenous and subcutaneous formulations.
DGAP-News: Proen .
DGAP-News: Proenkephalin (penKid(R)) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients
vom 16.12.2020, 10:00 Uhr
Bild: pixabay.com
DGAP-News: SphingoTec GmbH / Key word(s): Scientific publication/Statement
Proenkephalin (penKid(R)) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients
16.12.2020 / 10:00
The issuer is solely responsible for the content of this announcement.
The latest consensus meeting of international experts in critical care and nephrology supports the use of novel biomarkers in the prevention and management of Acute Kidney Injury (AKI)
The consensus recommends using a combination of damage and functional biomarkers together with clinical information for routine practice